These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21465637)

  • 21. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies.
    Alvarez O; Freeman A; Bedros A; Call SK; Volsch J; Kalbermatter O; Halverson J; Convy L; Cook L; Mick K
    J Pediatr Hematol Oncol; 1995 May; 17(2):145-50. PubMed ID: 7749764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
    Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
    Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
    Grunberg SM; Warr D; Gralla RJ; Rapoport BL; Hesketh PJ; Jordan K; Espersen BT
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S43-7. PubMed ID: 20972805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients.
    Sherani F; Boston C; Mba N
    Curr Oncol Rep; 2019 Aug; 21(10):89. PubMed ID: 31418119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: a prospective, observational study.
    Bodge M; Shillingburg A; Paul S; Biondo L
    Pediatr Blood Cancer; 2014 Jun; 61(6):1111-3. PubMed ID: 24357337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.
    Berrak SG; Ozdemir N; Bakirci N; Turkkan E; Canpolat C; Beker B; Yoruk A
    Support Care Cancer; 2007 Oct; 15(10):1163-8. PubMed ID: 17372773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the prevention and management of CINV.
    Natale JJ
    Am J Manag Care; 2018 Oct; 24(18 Suppl):S391-S397. PubMed ID: 30328690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
    Reindl TK; Geilen W; Hartmann R; Wiebelitz KR; Kan G; Wilhelm I; Lugauer S; Behrens C; Weiberlenn T; Hasan C; Gottschling S; Wild-Bergner T; Henze G; Driever PH
    Support Care Cancer; 2006 Feb; 14(2):172-6. PubMed ID: 16021478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.
    Herrstedt J; Muss HB; Warr DG; Hesketh PJ; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Hustad CM; Horgan KJ; Skobieranda F;
    Cancer; 2005 Oct; 104(7):1548-55. PubMed ID: 16104039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer.
    Flank J; Robinson PD; Holdsworth M; Phillips R; Portwine C; Gibson P; Maan C; Stefin N; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2016 Jul; 63(7):1144-51. PubMed ID: 26960036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
    Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation.
    Jordan K; Chan A; Gralla RJ; Jahn F; Rapoport B; Ruhlmann CH; Sayegh P; Hesketh PJ
    Support Care Cancer; 2023 Dec; 32(1):53. PubMed ID: 38129530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydration requirements in patients receiving highly emetogenic chemotherapy.
    Erickson R; Nebughr N; Mosier MC; Nibley W
    Future Oncol; 2019 Mar; 15(7):753-761. PubMed ID: 30499739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
    Bleiberg H; Hulstaert F; Buyse M; De Keyser P
    Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral intervention for reducing chemotherapy-related nausea and vomiting in adolescents with cancer.
    Lebaron S; Zeltzer L
    J Adolesc Health Care; 1984 Jul; 5(3):178-82. PubMed ID: 6735833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.